🎯 3 free searches remaining
Knight Therapeutics Inc. is a specialty pharmaceutical company focused on developing and distributing pharmaceutical and consumer health products. Key strengths include a solid gross margin of 48.3% and a strong liquidity position with a current ratio of 2.28. However, the company faces concerns with a negative net margin of -2.3% and low returns on equity and assets, indicating profitability challenges. While the gross margin is impressive, the negative net margin suggests potential inefficiencies or high costs that need addressing for sustainable growth.
Loading financial metrics...
No significant red flags identified
This company appears financially healthy on available metrics
Exceptional revenue growth of 42.3% YoY demonstrates strong market demand and competitive positioning.
Operating margin expanded by 7.2pp, demonstrating strong operational leverage.
Both gross margin (+1.6pp) and operating margin (+7.2pp) are expanding simultaneously, indicating the company is scaling profitably.
Operating cash flow surged 280.3% YoY, indicating strong cash generation capability.
Excellent operating cash flow margin of 21.1% indicates high-quality earnings.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.